Testosterone Replacement for Male Opioid Agonist Maintained Patients
NCT01873989
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
15
Enrollment
OTHER
Sponsor class
Conditions
Chronic Pain
Opioid Addiction
Symptomatic Hypogonadism
Interventions
DRUG:
Testosterone replacement
OTHER:
Waitlist control
Sponsor
Yale University